SCHEMBL2201656

SCHEMBL2201656

CCOc1cc(C(c2ccc(O)cc2)c2ccc(O)cc2)ccc1O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.57
ALDH1A1 P00352 2/20 0.57
GAA P10253 2/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
TP53 P04637 1/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MGAM O43451 1/20 0.47
TOP2A P11388 1/20 0.47
BCHE P06276 2/20 0.46
TYR P14679 2/20 0.46
ACHE P22303 2/20 0.46
CYP3A4 P08684 2/20 0.44
LMNA P02545 1/20 0.44
ESR1 P03372 1/20 0.44
CYP1A2 P05177 1/20 0.44
PGR P06401 1/20 0.44
CHRM2 P08172 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
AR P10275 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29499857 1.00 MAPT (0.57) MAPTALDH1A1GAASMN1; SMN2TP53
SCHEMBL1758270 0.95 ALDH1A1 (0.61) MAPTALDH1A1GAASMN1; SMN2TP53
SCHEMBL13416165 0.85 ALDH1A1 (0.59) MAPTALDH1A1GAASMN1; SMN2TP53
SCHEMBL2202046 0.84 ALDH1A1 (0.54) MAPTALDH1A1GAASMN1; SMN2TP53
SCHEMBL28250033 0.83 PTPRC (0.41) MAPTALDH1A1GAASMN1; SMN2TP53
SCHEMBL2202053 0.81 ALDH1A1 (0.52) MAPTALDH1A1GAASMN1; SMN2TP53
SCHEMBL10149066 0.81 ALDH1A1 (0.54) MAPTALDH1A1GAASMN1; SMN2TP53
SCHEMBL11569410 0.81 BCHE (0.58) MAPTALDH1A1GAASMN1; SMN2TP53
SCHEMBL9652071 0.81 GAA (0.54) MAPTALDH1A1GAASMN1; SMN2TP53
SCHEMBL757257 0.81 MAOB (0.62) GAAMEN1KMT2ABCHETYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2203783-A2 THICK FILM RESISTS AZ Electronic Materials USA Corp. (US) 2010-07-07 EP claimed
WO-2009040661-A2 THICK FILM RESISTS AZ ELECTRONIC MATERIALS USA CORP. (DE) 2009-04-02 WO claimed
US-20090081589-A1 THICK FILM RESISTS MERCK PATENT GMBH (DE) 2009-03-26 US claimed
EP-1623274-A2 PHOTORESIST COMPOSITIONS AZ Electronic Materials USA Corp. (US) 2006-02-08 EP claimed
WO-2004088423-A2 PHOTORESIST COMPOSITIONS AZ ELECTRONIC MATERIALS USA CORP. (US) 2004-10-14 WO claimed
US-20040197704-A1 Photoresist compositions AZ ELECTRONIC MATERIALS USA CORP. 2004-10-07 US claimed
US-6790582-B1 NOVOLAK RESIN PARTIALLY ESTERIFIED WITH NAPHTHOQUINONEDIAZIDOSULFONYL GROUP; DILUTION RESIN(S), AND SOLVENT CLARIANT FINANCE BVI LIMITED (VG) 2004-09-14 US claimed
CN-112750865-B Display panel 三星显示有限公司 2024-12-13 CN disclosed
CN-113544585-B Photosensitive resin composition, photosensitive resin sheet, cured film, method for producing cured film, organic EL display device, and electronic component 东丽株式会社 2024-10-22 CN disclosed
US-20240248396-A1 XANTHENE COMPOUND, RESIN COMPOSITION, CURED OBJECT, METHOD FOR PRODUCING CURED OBJECT, ORGANIC EL DISPLAY DEVICE, AND DISPLAY DEVICE TORAY INDUSTRIES, INC. (JP) 2024-07-25 US disclosed
CN-118251632-A Photosensitive resin composition, cured product, method for producing cured product, organic EL display device, and display device 东丽株式会社 2024-06-25 CN disclosed
US-11953830-B2 Photosensitive resin composition, photosensitive resin sheet, cured film, method for producing cured film, organic EL display device and electronic component TORAY INDUSTRIES, INC. (JP) 2024-04-09 US disclosed
CN-114207038-B Resin composition, method for producing cured product, pattern cured product, interlayer insulating film, covercoat, surface protective film, and electronic component 艾曲迪微系统股份有限公司 2024-03-22 CN disclosed
US-6475693-B1 Positively photosensitive resin composition CLARIANT FINANCE (BVI) LIMITED (VG) 2002-11-05 US disclosed
US-6391513-B1 ALKALI SOLUBLE NOVOLAK RESIN ESTERIFIED WITH 1,2-NAPHTHOQUINONEDIAZIDE-(4-OR 5-)SULFONIC ACID; LIQUID CRYSTAL DISPLAYS, SEMICONDUCTORS, INTEGRATED CIRCUITS CLARIANT FINANCE (BVI) LIMITED (VG) 2002-05-21 US disclosed
EP-1146394-A1 PHOTOSENSITIVE RESIN COMPOSITION AND METHOD FOR IMPROVING DRY ETCHING RESISTANCE OF PHOTOSENSITIVE RESIN COMPOSITION CLARIANT INTERNATIONAL LTD. (CH) 2001-10-17 EP disclosed
EP-1143298-A1 PHOTOSENSITIVE COMPOSITION CLARIANT INTERNATIONAL LTD. (CH) 2001-10-10 EP disclosed
EP-1067435-A1 POSITIVELY PHOTOSENSITIVE RESIN COMPOSITION Clariant International Ltd. (CH) 2001-01-10 EP disclosed
EP-1055969-A1 POSITIVELY PHOTOSENSITIVE RESIN COMPOSITION Clariant International Ltd. (CH) 2000-11-29 EP disclosed
EP-0943640-A1 HIGHLY HEAT-RESISTANT, HIGH-PURITY POLYARYLATE AND FILM PRODUCED FROM THE SAME UNITIKA LTD. (JP) 1999-09-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240248396-A1 XANTHENE COMPOUND, RESIN COMPOSITION, CURED OBJECT, METHOD FOR PRODUCING CURED OBJECT, ORGANIC EL DISPLAY DEVICE, AND DISPLAY DEVICE NLRP3, XPA, ASIC1 MAPT 940/4885ALDH1A1 1222/4885GAA 263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.